Cargando…
Benefit of cabazitaxel in previously treated metastatic castration-resistant prostate cancer; CARD trial
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759182/ https://www.ncbi.nlm.nih.gov/pubmed/33376276 http://dx.doi.org/10.4103/iju.IJU_160_20 |